The Oncology Institute, Inc. TOI Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s retained earnings?
- The Oncology Institute, Inc. (TOI) reported retained earnings of -$273.91M in Q1 2026.
- How has The Oncology Institute, Inc.'s retained earnings changed year-over-year?
- The Oncology Institute, Inc.'s retained earnings decreased by 18.9% year-over-year, from -$230.4M to -$273.91M.
- What is the long-term trend for The Oncology Institute, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s retained earnings has grown at a 39.0% compound annual growth rate (CAGR), from -$52.31M to -$271.42M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.